Results 171 to 180 of about 12,502 (244)

Prognosis and Risk Stratification of Patients with Advanced Heart Failure Followed-Up on an Outpatient Clinic. [PDF]

Biomedicines
Papaioannou E, Chatzipanteliadou S, Rammos A, Gkartzonikas I, Bechlioulis A, Stamou I, Bouratzis V, Lakkas L, Michalis LK, Naka KK.   +9 more
europepmc   +1 more source

The Anti-Inflammatory Potential of Levosimendan in Sepsis: An Experimental Study Using a LPS-Induced Rat Model. [PDF]

Life (Basel)
Dedeler Ertanıdır E, Duman I, Eryavuz DO, Ünlü A, Ertanıdır M, Duman A.   +5 more
europepmc   +1 more source

Levosimendan for postoperative subclinical heart failure after noncardiac surgery: a randomized, double-blinded, phase III trial. [PDF]

Nat Commun
Reiterer C, Kabon B, Taschner A, Graf A, Adamowitsch N, Horvath K, Emler D, Zotti O, Hantakova N, Hochreiter B, Fraunschiel M, Clement T, Fleischmann E.   +12 more
europepmc   +1 more source

Clinical Importance of Phosphodiesterase 3 Inhibitors on Outcomes in Patients With Cardiogenic Shock　- A Systematic Review. [PDF]

Circ Rep
Yamamoto M, Hosoya Y, Hanada H, Osawa T, Arai M, Sakamoto K, Okazaki Y, Katasako-Yabumoto A, Ishizu T, Kondo T, Kirigaya J, Nakayama N, Yamamoto T, Hashiba K, Nakashima T, Tsujita K, Noguchi T, Tsujimoto Y, Kikuchi M, Tahara Y, Nonogi H, Matoba T, Japan Resuscitation Council (JRC) Cardiogenic Shock (CS) Task Force and the Guideline Editorial Committee on behalf of the Japanese Circulation Society (JCS) Emergency and Critical Care Committee.   +22 more
europepmc   +1 more source

Survival differences according to baseline characteristics of patient with advanced heart failure treated with levosimendan. [PDF]

SAGE Open Med
Garcia-Peña AA, Mariño A, Muñoz-Velandia OM, Saa-González D.   +3 more
europepmc   +1 more source

Intravenous Levosimendan versus Milrinone: Coronary Sinus Lactate and PA Catheter Derived Parameters in Patients with Pulmonary Hypertension Undergoing Elective Mitral Valve Replacement. [PDF]

Ann Card Anaesth
Virmani S, Garg S, Malik I, Dash AC, Naqvi SEH, Wadhwa R, Singh H.   +6 more
europepmc   +1 more source

Clinical analysis of atrial fibrillation after levosimendan treatment for acute decompensated heart failure: A propensity score-matched study. [PDF]

Medicine (Baltimore)
Chen B, Chen Z, Gao Q, Li Q, Yang T.
europepmc   +1 more source

Levosimendan pharmacokinetics

Frontiers in Pharmacology, 2010
openaire   +1 more source

Inhibition of Mettl3 alleviates low-dose cisplatin-induced renal fibrosis and enhances the chemotherapeutic efficacy in mouse models of cancer. [PDF]

Int J Biol Sci
Xie Y, Li H, Pan J, Li Y, Zhang D.
europepmc   +1 more source